Committee Composition

Print Page   Print Page       E-mail Page   Email Page       RSS Feeds   RSS       E-mail Alerts  Email Alerts       Financial Tear Sheet  Tear Sheet

Committee Composition

Below is a summary of our committee structure and membership information.

Chairperson Chairperson Committee Member Member Audit committee financial expert Financial Expert
  Board Audit and Risk Compensation Nominating and Corporate Governance
David  W. Anstice*+  Committee Member   Chairperson  
Robert A. Breyer* Audit committee financial expert
Robert A. Breyer*

Mr. Breyer has been a director of Alkermes since July 1994. He served as the President of Alkermes from July 1994 until his retirement in December 2001 and Chief Operating Officer from July 1994 to February 2001. From August 1991 to December 1993, Mr. Breyer was President and General Manager of Eli Lilly Italy, a subsidiary of Eli Lilly and Company. From September 1987 to August 1991, he was Senior Vice President, Marketing and Sales of IVAC Corporation, a subsidiary of Eli Lilly and Company. Mr... 
Committee Member Committee Member   Committee Member
Shane Cooke 
Shane Cooke

Shane Cooke oversees corporate finance, commercial, human resources, business development, corporate planning and manufacturing operations, including the contract pharmaceutical services business. Mr. Cooke joined Alkermes as President upon completion of the merger between Elan Drug Technologies (EDT) and Alkermes, Inc. in September 2011. Previously, Mr. Cooke was Head of EDT and Executive Vice President of Elan from 2007 through the merger in 2011 and concurrently served as Chief Financial Offi... 
Committee Member      
Wendy L.  Dixon* 
Wendy L.  Dixon*

Dr. Dixon has been a director of Alkermes since January 2011. She has extensive experience in the pharmaceutical and biotech industry, combining a technical background with experience in drug development, regulatory affairs and marketing. She directed the launch of and growth of more than 20 pharmaceutical products. From 2001 to 2009 she was Chief Marketing Officer and President, Global Marketing for Bristol-Myers Squibb where she served on the Executive Committee. From 1996 to 2001 she was Seni... 
Committee Member     Chairperson
Richard B. Gaynor, M.D.* 
Richard B. Gaynor, M.D.*

Dr. Gaynor has been a director of Alkermes since September 2019. Since November 2016, he has served as President of Research and Development at Neon Therapeutics, a leading company in the field of neoantigen-targeted cancer therapies. Prior to joining Neon, Dr. Gaynor held clinical development and medical affairs roles at Eli Lilly and Company from August 2002 to October 2016, including serving as Senior Vice President, Clinical Development and Medical Affairs of Lilly Oncology.... 
Committee Member      
Paul J. Mitchell* Audit committee financial expert
Paul J. Mitchell*

Mr. Mitchell has been a director of Alkermes since April 2003. He served as the Chief Financial Officer and Treasurer of Kenet, Inc. from 2002 until 2009. Prior to joining Kenet, Mr. Mitchell was the Chief Financial Officer and Treasurer of Kopin Corporation from April 1985 through September 1998. From September 1998 through June 2001, Mr. Mitchell served in a consulting role at Kopin as Director of Strategic Planning. Prior to joining Kopin, Mr. Mitchell worked for the international accounting ... 
Committee Member Chairperson Committee Member  
Richard F. Pops 
Richard F. Pops
Chairman and Chief Executive Officer


Richard Pops serves as Chairman and Chief Executive Officer of Alkermes. He joined Alkermes as CEO in 1991. Under his leadership, Alkermes has grown from a privately held company with 25 employees to an international, publicly traded biopharmaceutical company with more than 2,000 employees. Alkermes has a diversified commercial product portfolio and a substantial clinical pipeline of central nervous system (CNS) product candidates. Mr. Pops currently serves on the Value and Coverage Advisory Cou... 
Chairperson      
Nancy L. Snyderman* 
Nancy L. Snyderman*

Dr. Snyderman has been a director of Alkermes since May 2016. She most recently served as Chief Medical Editor at NBC News, and has more than three decades of experience as a leading voice in healthcare and medicine. Dr. Snyderman is a board certified Otolaryngologist-Head and Neck Surgeon and Fellow in the American College of Surgeons. She currently serves on the Board of Directors of GE’s Healthymagination. Dr. Snyderman is a board member of the Institute for Healthcare Improvement in Cambridg... 
Committee Member Committee Member   Committee Member
Frank Anders (“Andy”) Wilson* 
Frank Anders (“Andy”) Wilson*

Mr. Wilson has been a director of Alkermes since September 2019. Mr. Wilson most recently served as Chief Financial Officer and Senior Vice President of PerkinElmer, Inc., a life sciences diagnostics, discovery and analytical solutions company, from 2009 to mid-2018, with responsibility for oversight of the organization’s growth strategy. Prior to PerkinElmer, Mr. Wilson... 
Committee Member      
Nancy J. Wysenski* 
Nancy J. Wysenski*

Ms. Wysenski has been a director of Alkermes since May 2013. From December 2009 through June 2012, Ms. Wysenski served as the Executive Vice President and Chief Commercial Officer of Vertex Pharmaceuticals Inc. Under her leadership, the commercial organization grew from 40 to 400 employees and the company’s first two product launches occurred. Prior to joining Vertex, Ms. Wysenski held the position of Chief Operating Officer of Endo Pharmaceuticals, where she led sales, marketing, commercial ope... 
Committee Member   Committee Member  

* denotes Independent Directors
+ denotes Lead Independent Director